"Given that CD38 actively degrades both NAD+ and NMN, it may be a useful approach to use CD38 inhibitors such as apigenin to increase NAD+ levels rather than try to boost them with precursors. In other words, it may be better to treat the cause of NAD+ loss rather than trying to compensate for it." (Lifespan.io)
Apigenin in cancer treatment